Square 1 Bank, the premier banking partner to entrepreneurs and the venture capital community, announced that it has provided a $10 million credit facility to new client Sebacia, Inc., a clinical-stage, private, medical device company dedicated to the treatment of dermatological conditions. Proceeds will be used to support the company's continued growth.

Founded in 2010 as part of The Innovation Factory, Sebacia is committed to the treatment of acne through new light-based treatments and procedures. Unlike other acne remedies such as medicated creams and pills, Sebacia's treatment utilizes microparticles in combination with hair removal lasers to treat targeted areas affected by acne. Through this physician-guided treatment, patients see results in just a few visits to their dermatologists, eliminating the need for often inconvenient and prolonged home treatments.

Mara Huntington, managing director of Square 1 Bank's life sciences practice, added, "With impressive backing from partners such as Domain Associates and Versant Ventures, Sebacia is definitely one to watch. Its management team, led by Anthony Lando, and innovative medical device technology have positioned the company for great success. We are excited to be Sebacia's banking partner and look forward to supporting it for years to come."  

Square 1 Bank is a full service commercial bank dedicated exclusively to serving the financial needs of the venture capital community and entrepreneurs in all stages of growth and expansion.

Sebacia, Inc. is a clinical-stage, private medical device company dedicated to creating breakthrough topical therapies for the treatment of dermatological conditions affecting millions of people. Sebacia's goal is to provide a better alternative to the daily use of topical and systemic drugs currently available for the treatment of acne.